Mizunuma N - Search Results

1

ALDH1A3-mTOR axis as a therapeutic target for anticancer drug-tolerant persister cells in gastric cancer.

Kawakami R, Mashima T, Kawata N, Kumagai K, Migita T, Sano T, Mizunuma N, Yamaguchi K, Seimiya H. Kawakami R, et al. Among authors: mizunuma n. Cancer Sci. 2020 Mar;111(3):962-973. doi: 10.1111/cas.14316. Epub 2020 Feb 11. Cancer Sci. 2020. PMID: 31960523 Free PMC article.

2

Serum VEGF-A and CCL5 levels as candidate biomarkers for efficacy and toxicity of regorafenib in patients with metastatic colorectal cancer.

Suenaga M, Mashima T, Kawata N, Wakatsuki T, Horiike Y, Matsusaka S, Dan S, Shinozaki E, Seimiya H, Mizunuma N, Yamaguchi K, Yamaguchi T. Suenaga M, et al. Among authors: mizunuma n. Oncotarget. 2016 Jun 7;7(23):34811-23. doi: 10.18632/oncotarget.9187. Oncotarget. 2016. PMID: 27166185 Free PMC article.

3

Retrospective study of RAS/PIK3CA/BRAF tumor mutations as predictors of response to first-line chemotherapy with bevacizumab in metastatic colorectal cancer patients.

Nakayama I, Shinozaki E, Matsushima T, Wakatsuki T, Ogura M, Ichimura T, Ozaka M, Takahari D, Suenaga M, Chin K, Mizunuma N, Yamaguchi K. Nakayama I, et al. Among authors: mizunuma n. BMC Cancer. 2017 Jan 9;17(1):38. doi: 10.1186/s12885-016-2994-6. BMC Cancer. 2017. PMID: 28068936 Free PMC article.

4

Blockade of bulky lymphoma-associated CD55 expression by RNA interference overcomes resistance to complement-dependent cytotoxicity with rituximab.

Terui Y, Sakurai T, Mishima Y, Mishima Y, Sugimura N, Sasaoka C, Kojima K, Yokoyama M, Mizunuma N, Takahashi S, Ito Y, Hatake K. Terui Y, et al. Among authors: mizunuma n. Cancer Sci. 2006 Jan;97(1):72-9. doi: 10.1111/j.1349-7006.2006.00139.x. Cancer Sci. 2006. PMID: 16367924 Free PMC article.

5

Circulating tumor cells as a surrogate marker for determining response to chemotherapy in patients with advanced gastric cancer.

Matsusaka S, Chìn K, Ogura M, Suenaga M, Shinozaki E, Mishima Y, Terui Y, Mizunuma N, Hatake K. Matsusaka S, et al. Among authors: mizunuma n. Cancer Sci. 2010 Apr;101(4):1067-71. doi: 10.1111/j.1349-7006.2010.01492.x. Epub 2010 Jan 12. Cancer Sci. 2010. PMID: 20219073 Free PMC article.

6

Serum leucine-rich alpha-2-glycoprotein-1 with fucosylated triantennary N-glycan: a novel colorectal cancer marker.

Shinozaki E, Tanabe K, Akiyoshi T, Tsuchida T, Miyazaki Y, Kojima N, Igarashi M, Ueno M, Suenaga M, Mizunuma N, Yamaguchi K, Nakayama K, Iijima S, Yamaguchi T. Shinozaki E, et al. Among authors: mizunuma n. BMC Cancer. 2018 Apr 11;18(1):406. doi: 10.1186/s12885-018-4252-6. BMC Cancer. 2018. PMID: 29642865 Free PMC article.

7

[Phase I / II study of XELOX plus bevacizumab in Japanese patients with metastatic colorectal cancer(JO19380)].

Sato A, Doi T, Boku N, Kato K, Komatsu Y, Yamaguchi K, Muro K, Hamamoto Y, Koizumi W, Mizunuma N, Takiuchi H. Sato A, et al. Among authors: mizunuma n. Gan To Kagaku Ryoho. 2011 Apr;38(4):561-9. Gan To Kagaku Ryoho. 2011. PMID: 21498982 Clinical Trial. Japanese.

8

Circulating tumor cells as a surrogate marker for determining response to chemotherapy in Japanese patients with metastatic colorectal cancer.

Matsusaka S, Suenaga M, Mishima Y, Kuniyoshi R, Takagi K, Terui Y, Mizunuma N, Hatake K. Matsusaka S, et al. Among authors: mizunuma n. Cancer Sci. 2011 Jun;102(6):1188-92. doi: 10.1111/j.1349-7006.2011.01926.x. Epub 2011 Apr 11. Cancer Sci. 2011. PMID: 21401804 Free article.

9

Leukocytoclastic vasculitis with purpura and renal failure induced by the anti-epidermal growth factor receptor antibody panitumumab: a case report.

Kamo H, Shinozaki E, Sugase T, Mizunuma N, Taniguchi S, Gotoh T, Chin K, Tanaka T, Koga K, Yamaguchi K. Kamo H, et al. Among authors: mizunuma n. J Med Case Rep. 2019 Jan 16;13(1):13. doi: 10.1186/s13256-018-1877-7. J Med Case Rep. 2019. PMID: 30646927 Free PMC article.

10

Circulating endothelial progenitors and CXCR4-positive circulating endothelial cells are predictive markers for bevacizumab.

Matsusaka S, Mishima Y, Suenaga M, Terui Y, Kuniyoshi R, Mizunuma N, Hatake K. Matsusaka S, et al. Among authors: mizunuma n. Cancer. 2011 Sep 1;117(17):4026-32. doi: 10.1002/cncr.25977. Epub 2011 Feb 24. Cancer. 2011. PMID: 21858803 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129 results

Search Page

Filters